Cheviot Value Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1427147
BEVERLY HILLS, CA
Position in LGND
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$39,930
+$2,116 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Cheviot Value Management, LLC holds $87,219 across 11 Biotechnology names. LGND ranks #1 (45.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
200 | $39,930 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
796 | $25,479 | |
| 3 | TECH |
BIO-TECHNE Corp
|
172 | $8,988 | |
| 4 | BHVN |
Biohaven Ltd.
|
750 | $6,345 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
28 | $2,102 | |
| 6 | GNPX |
Genprex, Inc.
|
1,000 | $1,810 | |
| 7 | OABIW |
OmniAb, Inc.
|
980 | $1,538 | |
| 8 | MNKD |
Mannkind Corp
|
200 | $490 |
All Filings in LGND
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,930 | 200 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $37,814 | 200 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $35,428 | 200 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $22,736 | 200 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,028 | 200 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||